$5.56
0.54% day before yesterday
Nasdaq, Jun 28, 10:11 pm CET
ISIN
US0162591038
Symbol
ALIM
Sector
Industry

Alimera Sciences, Inc. Target price 2024 - Analyst rating & recommendation

Alimera Sciences, Inc. Classifications & Recommendation:

Hold
100%

Alimera Sciences, Inc. Target price

Target price $6.75
Course $5.56
Price potential
Number of estimates 4
4 Analysts have issued a price target Alimera Sciences, Inc. 2025 . The average Alimera Sciences, Inc. target price is $6.75. This is higher than the current share price. The highest price target is , the lowest is .
A rating was issued by 4 analysts: 0 Analysts recommend Alimera Sciences, Inc. to buy, 4 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst estimates: Analysts believe that the Alimera Sciences, Inc. share has an average upside potential 2025 of . Most analysts recommend the Alimera Sciences, Inc. share at Hold.

Sales and margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Turnover Million $ 80.75 106.07
49.18% 31.36%
EBITDA margin 9.02% 19.87%
154.65% 120.40%
Net margin -54.48% -3.46%
78.26% 93.65%

4 Analysts have issued a sales forecast Alimera Sciences, Inc. 2024 . The average Alimera Sciences, Inc. sales estimate is

$106m
unlock
. This is
17.57% higher
unlock
than the turnover of the last 12 months(TTM). The highest sales forecast is
$108m 19.71%
unlock
, the lowest is
$105m 16.60%
unlock
.

This results in the following potential growth figures:

Sales forecast

2023 $80.8m 49.18%
2024
$106m 31.36%
unlock
2025
$121m 14.10%
unlock
2026
$136m 12.29%
unlock
2027
$191m 40.89%
unlock
2028
$229m 19.82%
unlock

2 Analysts have issued an Alimera Sciences, Inc. EBITDA forecast 2024. The average Alimera Sciences, Inc. EBITDA estimate is

$21.1m
unlock
. This is
94.11% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$21.2m 94.85%
unlock
, the lowest is
$21.0m 93.37%
unlock
.

This results in the following potential growth figures and future EBITDA margins:

EBITDA forecast

2023 $7.3m 181.52%
2024
$21.1m 189.57%
unlock
2025
$33.4m 58.46%
unlock
2026
$46.8m 39.99%
unlock
2027
$88.4m 88.95%
unlock
2028
$118m 33.58%
unlock

EBITDA margin

2023 9.02% 154.65%
2024
19.87% 120.40%
unlock
2025
27.60% 38.90%
unlock
2026
34.41% 24.67%
unlock
2027
46.14% 34.09%
unlock
2028
51.44% 11.49%
unlock

4 Alimera Sciences, Inc. Analysts have issued a net profit forecast 2024. The average Alimera Sciences, Inc. net profit estimate is

$-3.7m
unlock
. This is
95.54% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$5.2m 106.37%
unlock
, the lowest is
$-8.9m 89.18%
unlock
.

This results in the following potential growth figures and future net margins:

Net profit forecast

2023 $-44.0m 67.57%
2024
$-3.7m 91.66%
unlock
2025
$10.0m 371.12%
unlock
2026
$22.5m 126.33%
unlock
2027
$52.9m 134.86%
unlock
2028
$81.7m 54.47%
unlock

Net margin

2023 -54.48% 78.26%
2024
-3.46% 93.65%
unlock
2025
8.22% 337.57%
unlock
2026
16.57% 101.58%
unlock
2027
27.62% 66.69%
unlock
2028
35.61% 28.93%
unlock

Earnings per share, P/E ratio and EV/sales forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Forecast
Earnings per share $ -0.84 -0.07
67.57% 91.67%
P/E ratio negative
EV/Sales 3.29

4 Analysts have issued a Alimera Sciences, Inc. forecast for earnings per share. The average Alimera Sciences, Inc. <a href=/blog/eps>EPS is

$-0.07
unlock
. This is
95.54% higher
unlock
than earnings per share in the financial year 2023. The highest <a href=/blog/eps>EPS forecast is
$0.10 106.37%
unlock
, the lowest is
$-0.17 89.17%
unlock
.

This results in the following potential growth figures and future valuations:

Earnings per share

2023 $-0.84 67.57%
2024
$-0.07 91.67%
unlock
2025
$0.19 371.43%
unlock
2026
$0.43 126.32%
unlock
2027
$1.01 134.88%
unlock
2028
$1.56 54.46%
unlock

P/E ratio

Current -3.55 168.94%
2024
-79.43 2,137.46%
unlock
2025
29.26 136.84%
unlock
2026
12.93 55.81%
unlock
2027
5.50 57.46%
unlock
2028
3.56 35.27%
unlock

Based on analysts' sales estimates for 2024, the Alimera Sciences, Inc. share is valued at an <a href=/blog/ev-sales-einfach-erklaert>EV/Sales of

and an <a href=/blog/kurs-umsatz-verhaeltnis-kuv-einfach-erklaert>P/S ratio of .

This results in the following potential growth figures and future valuations:

EV/Sales

Current 3.87 245.54%
2024
3.29 14.94%
unlock
2025
2.89 12.36%
unlock
2026
2.57 10.95%
unlock
2027
1.82 29.03%
unlock
2028
1.52 16.54%
unlock

P/S ratio

Current 3.23 790.65%
2024
2.75 14.95%
unlock
2025
2.41 12.36%
unlock
2026
2.14 10.94%
unlock
2027
1.52 29.03%
unlock
2028
1.27 16.54%
unlock

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now